| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 736994 | 1-(naphthalen-2-yl)-2-(3,4,5-trimethoxyphenyl)-1H-imidazole | 0.0238174255956147 | 0.26095378 |
| NSC 737698 | Null | 0.0238174255956147 | 0.39230549 |
| NSC 740345 | 3-3'-(1H-pyrazole-3,5-diyl)bis(1-methyl-1H-indole) | 0.0238174255956147 | 0.22007828 |
| NSC 741291 | 6-(3-hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one | 0.0238174255956147 | 0.38211029 |
| NSC 742554 | 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, | 0.0238174255956147 | 0.47384888 |
| NSC 77038 | WR 141 | 0.0238174255956147 | 0.26468368 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.024108502230778 | 0.17440022 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.024108502230778 | 0.10049798 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.024108502230778 | 0.24415177 |
| NSC 175493 | Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- | 0.024108502230778 | 0.35815168 |